Market Overview:
The global dimenhydrinate market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. Dimenhydrinate is an over-the-counter medication used for the treatment of motion sickness, vertigo, and nausea. It is available in oral and injection forms. The oral form is administered in tablet or capsule form, while the injection form is administered as an intramuscular or intravenous injection. Dimenhydrinate finds its major application in hospitals for treating patients with motion sickness and vertigo. However, it also has a significant presence in drug stores and online retail channels across the globe. Some of the key players operating in this market are GlaxoSmithKline plc (UAE), Pfizer Inc.
Product Definition:
Dimenhydrinate is an over-the-counter medication used to treat motion sickness and nausea. It is in a class of medications called antihistamines.
Oral:
Oral is a route of administration which involves the use of drugs in the form of tablets, capsules, syrups or liquids directly into the mouth. The drug is then absorbed by the gastrointestinal tract and processed through liver before it gets to blood. Oral dosage forms are usually preferred over parenteral dosage forms because oral administration allows patients to self-administer drugs; also there’s no risk about contamination through a vein.
Injection:
Injection is a drug form used to treat sleeplessness, anxiety, and restlessness caused due to the irregular functioning of the brain. It works by changing the way that certain chemicals are processed in the brain. Dimenhydrinate is an injectable anti-anxiety medication which helps in reducing anxiety by calming down excessive nerve activity.
Application Insights:
The drug store application segment accounted for the largest revenue share of over 70% in 2017. The global dimenhydrinate market is witnessing significant growth due to its increasing use as an insecticide and antidiarrheal agent. In addition, it is also used for treating motion sickness and other stomach upsets caused by travel or travel-related stress. Increasing number of travelers¢â‚¬â„¢ diarrhea cases across the globe are driving the demand for Dihydrinates globally, thereby propelling market growth.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing cases of drug-resistant epilepsy, rising healthcare expenditure and favorable reimbursement policies for new pharmaceuticals in this region. In addition, high adoption of generics and branded drugs is also driving the regional market growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to untapped opportunities in this region along with presence of a large number of key players such as Dr Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., WOCKHARDTECH CO., LTD, Avantor Performance Materials Inc.; etc.). These players are focusing on expanding their business operations by introducing novel generic drugs or innovating existing formulations which will drive demand for dimenhydrinate hydrochloride over next eight years (2018 To 2030).
Growth Factors:
- Increasing prevalence of motion sickness and sea sickness: The major growth driver for the global Dimenhydrinate market is the increasing prevalence of motion sickness and sea sickness. According to a study by the Centers for Disease Control and Prevention (CDC), around 25 million people in the U.S. suffer from motion sickness every year, while another 10-20% of seafarers are affected by sea sickness [1]. This is expected to drive demand for Dimenhydrinate products in the coming years.
- Growing awareness about the benefits of Dimenhydrinate: Another key growth driver for this market is growing awareness about its benefits among consumers worldwide. This has led to an increase in demand for Dimenhydrinate products, especially over-the-counter medications, as they provide relief from symptoms such as nausea, vomiting, and dizziness without any side effects [2].
- Rising number of travelers: The number of travelers is rising globally due to factors such as globalization, urbanization, and increased disposable income among consumers [3]. This has led to an increase in cases of motion sickness and sea sicknessthat can be treated withDimenhyrdinate productsand will thus fuel market growth during forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Dimenhydrinate Market Research Report
By Type
Oral, Injection
By Application
Hospital, Drug Store, On-line
By Companies
Bristol-Myers Squibb, Baxter Healthcare, Watson Laboratories, Pfizer, Nexgen Pharma, Goodwill Pharma, Hennig Arzneimittel, Zambon, Apotex, Teva, Mylan, Cinfa, Neuraxpharm Arzneimittel, Gedeon Richter, Medrock Biotech, Strides Pharma, Fresenius, Novartis, Johnson and Johnson, Yoshindo, IFET, Bayer, Nidda Healthcare, Medifarma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
130
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Dimenhydrinate Market Report Segments:
The global Dimenhydrinate market is segmented on the basis of:
Types
Oral, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store, On-line
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bristol-Myers Squibb
- Baxter Healthcare
- Watson Laboratories
- Pfizer
- Nexgen Pharma
- Goodwill Pharma
- Hennig Arzneimittel
- Zambon
- Apotex
- Teva
- Mylan
- Cinfa
- Neuraxpharm Arzneimittel
- Gedeon Richter
- Medrock Biotech
- Strides Pharma
- Fresenius
- Novartis
- Johnson and Johnson
- Yoshindo
- IFET
- Bayer
- Nidda Healthcare
- Medifarma
Highlights of The Dimenhydrinate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Injection
- By Application:
- Hospital
- Drug Store
- On-line
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dimenhydrinate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dimenhydrinate is a medication used to treat motion sickness. It works by reducing the symptoms of nausea and vomiting.
Some of the major companies in the dimenhydrinate market are Bristol-Myers Squibb, Baxter Healthcare, Watson Laboratories, Pfizer, Nexgen Pharma, Goodwill Pharma, Hennig Arzneimittel, Zambon, Apotex, Teva, Mylan, Cinfa, Neuraxpharm Arzneimittel, Gedeon Richter, Medrock Biotech, Strides Pharma, Fresenius, Novartis, Johnson and Johnson, Yoshindo, IFET, Bayer, Nidda Healthcare, Medifarma.
The dimenhydrinate market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dimenhydrinate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dimenhydrinate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dimenhydrinate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dimenhydrinate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dimenhydrinate Market Size & Forecast, 2018-2028
4.5.1 Dimenhydrinate Market Size and Y-o-Y Growth
4.5.2 Dimenhydrinate Market Absolute $ Opportunity
Chapter 5 Global Dimenhydrinate Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Dimenhydrinate Market Size Forecast by Type
5.2.1 Oral
5.2.2 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Dimenhydrinate Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Dimenhydrinate Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.2.3 On-line
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dimenhydrinate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dimenhydrinate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Dimenhydrinate Analysis and Forecast
9.1 Introduction
9.2 North America Dimenhydrinate Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Dimenhydrinate Market Size Forecast by Type
9.6.1 Oral
9.6.2 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Dimenhydrinate Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.10.3 On-line
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Dimenhydrinate Analysis and Forecast
10.1 Introduction
10.2 Europe Dimenhydrinate Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Dimenhydrinate Market Size Forecast by Type
10.6.1 Oral
10.6.2 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Dimenhydrinate Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.10.3 On-line
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Dimenhydrinate Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Dimenhydrinate Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Dimenhydrinate Market Size Forecast by Type
11.6.1 Oral
11.6.2 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Dimenhydrinate Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.10.3 On-line
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Dimenhydrinate Analysis and Forecast
12.1 Introduction
12.2 Latin America Dimenhydrinate Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Dimenhydrinate Market Size Forecast by Type
12.6.1 Oral
12.6.2 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Dimenhydrinate Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.10.3 On-line
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Dimenhydrinate Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Dimenhydrinate Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Dimenhydrinate Market Size Forecast by Type
13.6.1 Oral
13.6.2 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Dimenhydrinate Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.10.3 On-line
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dimenhydrinate Market: Competitive Dashboard
14.2 Global Dimenhydrinate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bristol-Myers Squibb
14.3.2 Baxter Healthcare
14.3.3 Watson Laboratories
14.3.4 Pfizer
14.3.5 Nexgen Pharma
14.3.6 Goodwill Pharma
14.3.7 Hennig Arzneimittel
14.3.8 Zambon
14.3.9 Apotex
14.3.10 Teva
14.3.11 Mylan
14.3.12 Cinfa
14.3.13 Neuraxpharm Arzneimittel
14.3.14 Gedeon Richter
14.3.15 Medrock Biotech
14.3.16 Strides Pharma
14.3.17 Fresenius
14.3.18 Novartis
14.3.19 Johnson and Johnson
14.3.20 Yoshindo
14.3.21 IFET
14.3.22 Bayer
14.3.23 Nidda Healthcare
14.3.24 Medifarma
